PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Everyday discrimination impacts mental health

2014-09-15
(Press-News.org) Researchers have determined that African Americans and Caribbean blacks who experience discrimination of multiple types are at substantially greater risk for a variety of mental disorders including anxiety, depression and substance abuse.

The research — co-authored by professor Christopher Salas-Wright at The University of Texas at Austin's School of Social Work and published in the August 2014 edition of Addictive Behaviors — suggests that experiences of discrimination in the form of disrespect and condescension do not alone appear to increase risk for most mental disorders. However, hostile and character-based discrimination in combination with disrespect and condescension does seem to place African American and Caribbean black adults at considerable risk for mental health problems.

"When it comes to mental health, our results suggest that the type and frequency of discrimination matters," Salas-Wright said. "It seems that it is the ongoing experience of multiple types of discrimination, including disrespect, condescension, hostile and character-based discrimination, which negatively impacts mental health."

The study was co-authored with Trenette Clark (lead author) from the School of Social Work at the University of North Carolina, Chapel Hill; Michael G. Vaughn of the College for Public Health and Social Justice at Saint Louis University; and Keith E. Whitfield of the Center for Biobehavioral Health Disparities Research at Duke University.

"Perceived discrimination is an often overlooked but major source of health-related stress, with effects comparable to other major stressors such as the death of a loved one or the loss of a job," Clark said. "Our study shows that the risk for mental health and behavioral disorders varies according to the types and frequency of discriminatory experiences."

Researchers used data from the National Survey of American Life, a comprehensive survey of the mental health of black and non-Hispanic white populations in the United States funded by the National Institute of Mental Health. Findings are based on a nationally representative sample of 4,462 African American and Caribbean black respondents between 18 and 65 years of age.

The study measured the frequency of perceived discrimination of different types through questions such as "How often do you receive poorer service than others at restaurants or stores?" (disrespectful discrimination), "How often do people act as if they're better than you are" (condescending discrimination), "How often are you viewed as dishonest?" (character-based discrimination), and "How often are you threatened or harassed?" (hostile discrimination).

The vast majority of respondents (83%) reported having experienced some type of discrimination during the past year. Half of respondents (50%) reported recurrent experiences of discrimination of all types, and approximately one-seventh (14.7%) reported frequent experiences of discrimination of all types. Members of these last two groups were significantly more likely to report symptoms for major depressive disorder, and for alcohol-use and illicit drug-use disorders.

"Although most of our sample reported recent discrimination, most did not report mental health and substance use disorders, which speaks to their strength and resilience," Clark noted. "Factors such as ethnic identity, spirituality and religiosity have been found to help protect against risk factors such as everyday discrimination."

INFORMATION: For more information, contact Andrea Campetella, School of Social Work, 512-471-1458.


ELSE PRESS RELEASES FROM THIS DATE:

Results of PARTNER I trial reported at TCT 2014

2014-09-15
WASHINGTON, DC – September 13, 2014 – New data from a landmark clinical trial found that after five years, transcatheter aortic valve replacement (TAVR) demonstrated a persistent mortality benefit, improved functional status, and resulted in a lower rate of repeat hospitalizations when compared with standard therapy for patients with severe aortic stenosis who are not candidates for surgery. Findings were reported today at the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT ...

Results of US CoreValve High Risk Trial reported at TCT 2014

2014-09-15
WASHINGTON, DC – September 13, 2014 – According to a new study, transcatheter aortic valve replacement (TAVR) provided meaningful clinical benefits relative to surgical aortic valve replacement (SAVR) in high risk patients with incremental costs considered acceptable from a US perspective. Findings from the cost-effectiveness analysis of the US CoreValve High Risk Trial were reported today at the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational ...

Results of CLEAN-TAVI trial reported at TCT 2014

2014-09-15
WASHINGTON, DC – September 13, 2014 – A first-of-its kind study found that using a cerebral protection device during transcatheter aortic valve replacement (TAVR) can significantly reduce the number and volume of cerebral lesions in high risk patients with severe aortic stenosis. Findings were reported today at the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. Stroke remains ...

Two-year results of the CoreValve US Pivotal trial reported at TCT 2014

2014-09-15
WASHINGTON, DC – September 13, 2014 – In extended follow-up from a clinical trial, a self-expanding transcatheter aortic valve was shown to have low rates of all-cause mortality and major stroke. Findings were reported today at the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. Degenerative aortic stenosis is a progressive disease with a poor prognosis in the absence of surgical ...

Results of ISAR-CLOSURE trial reported at TCT 2014

2014-09-15
WASHINGTON, DC – September 13, 2014 – A new clinical trial found that vascular closure devices (VCD) are non-inferior to manual compression in patients undergoing transfemoral coronary angiography. Findings were reported today at the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. Vascular closure devices help achieve more rapid hemostasis after coronary angiography, however ...

International study identifies new genetic variants indicating risk for prostate cancer

2014-09-15
An international study co-led by Keck School of Medicine of the University of Southern California (USC) scientists and researchers in the United Kingdom has revealed 23 new genetic susceptibility locations indicating risk for prostate cancer. The data study, analyzing more than 87,000 individuals of European, African, Japanese and Latino ancestry, is the largest of its kind and is the first that combines multiple studies across different ethnic populations. "The goal of this research is to identify regions of the genome that contribute susceptibility to prostate cancer ...

Contaminated water in 2 states linked to faulty shale gas wells

2014-09-15
DURHAM, N.C. -- Faulty well integrity, not hydraulic fracturing deep underground, is the primary cause of drinking water contamination from shale gas extraction in parts of Pennsylvania and Texas, according to a new study by researchers from five universities. The scientists from Duke, Ohio State, Stanford, Dartmouth and the University of Rochester published their peer-reviewed study Sept. 15 in the Proceedings of the National Academy of Sciences. Using noble gas and hydrocarbon tracers, they analyzed the gas content of more than 130 drinking water wells in the two ...

Gut bacteria tire out T cells

2014-09-15
Leaky intestines may cripple bacteria-fighting immune cells in patients with a rare hereditary disease, according to a study by researchers in Lausanne, Switzerland. The study, published in The Journal of Experimental Medicine on September 15, may explain why these patients suffer from recurrent bacterial infections. Patients with a disease called common variable immunodeficiency (CVID) suffer from recurrent bacterial infections as a result of faulty immune cells. But despite these immune defects, CVID patients rarely contract viral infections. New data from Matthieu ...

T-bet tackles hepatitis

2014-09-15
A single protein may tip the balance between ridding the body of a dangerous virus and enduring life-long chronic infection, according to a report appearing in The Journal of Experimental Medicine. Hepatitis B and C viruses cause chronic infections in roughly three-quarters of infected people, putting these individuals at risk for developing liver diseases including cirrhosis and cancer. A few patients successfully eliminate infection, thanks primarily to virus-fighting immune cells called CD8+ T cells. The protective effects of CD8+ T cells depend on a cellular protein ...

Gas leaks from faulty wells linked to contamination in some groundwater

2014-09-15
COLUMBUS, Ohio—A study has pinpointed the likely source of most natural gas contamination in drinking-water wells associated with hydraulic fracturing, and it's not the source many people may have feared. What's more, the problem may be fixable: improved construction standards for cement well linings and casings at hydraulic fracturing sites. A team led by a researcher at The Ohio State University and composed of researchers at Duke, Stanford, Dartmouth, and the University of Rochester devised a new method of geochemical forensics to trace how methane migrates under ...

LAST 30 PRESS RELEASES:

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

[Press-News.org] Everyday discrimination impacts mental health